Skip to main content
. 2015 Apr 22;79(5):847–859. doi: 10.1111/bcp.12552

Figure 2.

Figure 2

Kaplan−Meier curve showing time to first serious safety warning or removal from market for new active substances: approval through NOC/c vs. standard review. Inline graphic, NOC/c; Inline graphic, standard review. Curves significantly different, P = 0.0113, log rank (Mantel−Cox) test